Key facts
- Genecis’s last known valuation is $40.0M (Jul 2022).
- It has raised $20.0M; the latest was Later Stage VC in Apr 2026.
- Notable investors include Y Combinator, Creative Destruction Lab, Khosla Ventures, Liquid 2 Ventures, University of Toronto — 48 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 48 names
- ·Watchlist + deal alerts for Genecis
- ·The full record, as it builds
Funding rounds
No funding rounds for Genecis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Genecis
Operator of a climate biotech company intended to convert waste into polymers, including polyhydroxyalkanoate bioplastics. The company's products include bio-based and biodegradable plastic, single-use foodware and packaging, three-dimensional-printing filaments, and the moldable plastic needed for the printing process, enabling customers to dispose of waste in a biodegradable manner.
- Sector
- Materials and Resources
- HQ
- Toronto, Canada
- Founded
- 2017
- Employees
- 14
- Website
- genecis.co/
- Ownership
- Privately Held (backing)
Genecis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Genecis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Genecis in its N-PORT filings yet. We sweep new filings monthly.